Galaxy Biosolutions (private company)

See something wrong or missing? Let us know
Offices:Gothenburg
Business model:B2B

Galaxy Biosolutions is a biotech startup in Sweden developing next gen sweeteners that can replace sugar in food by developing fermentation-based technologies using tailored microbes in order to can replace high-energy requiring chemical methods while also making use of biowaste

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Galaxy Biosolutions

Name Criteria
Belgium Aphea.Bio
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Iceland Atmonia
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Bainan Biotech
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
France BeFC
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
United Kingdom Better Dairy
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark Biograil
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Lithuania Biomatter Designs
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Switzerland Bionomous
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Denmark BioPhero
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Germany CatalYm
42%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 1
Top